Jefferies Starts Opko Health (OPK) at Buy

Article Stock Quotes (1) Comments (0)

Jefferies initiates coverage on Opko Health (NYSE: OPK) with a Buy rating and $8 price target.

The firm comments, "OPK is not a typical biotech/healthcare company, rather it is a holding company with constantly evolving investment in product/technology for risk diversification and growth enhancement. While unquantifiable value of OPK shares lies in Dr. Phillip Frost's track record (CEO at OPK, chairman of board at TEVA), we view its diversified portfolio as attractive for significant upside opportunities at limited downside risks."

For an analyst ratings summary and ratings history on Opko Health click here. For more ratings news on Opko Health click here.

Shares of Opko Health closed at $5.11 yesterday, with a 52 week range of $2.80-$5.57.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Topeka Capital Starts Laredo Petroleum (LPI) at Buy, Assets 'Undervalued'
• Avondale Partners Starts Tractor Supply Company (TSCO) at Market Outperform
• Topeka Capital Starts Precision Castparts (PCP) at Buy

Create E-mail Alert Related Categories

New Coverage

Related Entities

Jefferies & Co

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?